✦ LIBER ✦

Effects of changes in basal/total daily insulin ratio in type 2 diabetes patients on intensive insulin therapy including insulin glargine (JUN-LAN Study 6)

✍ Scribed by Motoyuki Tamaki; Tomoaki Shimizu; Akio Kanazawa; Yoshio Fujitani; Hirotaka Watada; Ryuzo Kawamori; Takahisa Hirose

Book ID: 116406205
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 221 KB
Volume: 81
Category: Article
ISSN: 0168-8227
DOI: 10.1016/j.diabres.2008.03.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of exercise-induced hypoglycaemia i

Risk of exercise-induced hypoglycaemia in patients with type 2 diabetes on intensive insulin therapy: Comparison of insulin glargine with NPH insulin as basal insulin supplement

✍ Ursula Plöckinger; Mendaha Topuz; Brigitte Riese; Thomas Reuter 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 179 KB

A Comparison of Twice-Daily Biphasic Ins

A Comparison of Twice-Daily Biphasic Insulin Aspart 70/30 and Once-Daily Insulin Glargine in Persons with Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Therapy: A Randomized, Open-Label Study

✍ Ligthelm, Robert; Gylvin, Titus; DeLuzio, Tony; Raskin, Philip 📂 Article 📅 2011 🏛 American Association of Clinical Endocrinologists 🌐 English ⚖ 781 KB

Response to Comment on: Bergenstal et al

Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140-2147

✍ Bergenstal, R. M.; Rosenstock, J.; Arakaki, R. F.; Prince, M. J.; Qu, Y.; Sinha, 📂 Article 📅 2013 🏛 American Diabetes Association 🌐 English ⚖ 48 KB

PDB54 COMPARISON OF TREATMENT COSTS BETW

PDB54 COMPARISON OF TREATMENT COSTS BETWEEN BASAL-SUPPORTED ORAL THERAPY (BOT) WITH INSULIN GLARGINE (GLA) AND BOT WITH INSULIN DETEMIR (DET) IN PATIENTS WITH TYPE 2 DIABETES (T2D): ECONOMIC EVALUATION BASED ON THE RESULTS OF THE INSULIN GLARGINE (LANTUS®) VERSUS INSULIN DETEMIR (LEVEMIR®) TREAT-TO-TARGET (L2T3) STUDY

✍ PK Schädlich; KC Koltermann; FW Dippel; EG Hagenmeyer; B Häussler 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Transferring to insulin detemir from NPH

Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVE™

✍ A. Dornhorst; H.-J. Lüddeke; C. Koenen; M. Meriläinen; A. King; A. Robinson; S. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Effect of targeting normal fasting gluco

Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes

✍ M. Hanefeld; C. Koehler; C. Hoffmann; K. Wilhelm; W. Kamke; H. Gerstein 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB